Cell-free circulating tumor DNA in plasma of non-small cell lung cancer patients: The role in EGFR T790 M mutation testing

被引：0
|
作者：
Sekerus, V. [1 ,2 ]
Stojanovic, G. [1 ]
Bursac, D. [1 ,2 ]
Tegeltija, D. [1 ,2 ]
Stolic, M. [3 ]
Andrijevic, I. [1 ,2 ]
机构：
[1] Inst Pulm Dis Vojvodina, Sremska Kamen, Serbia
[2] Univ Novi Sad, Fac Med, Novi Sad, Serbia
[3] Special Hosp Lung Dis Dr Jovan Bulajic, Brezovik, Montenegro
来源：
CLINICA CHIMICA ACTA | 2019年 / 493卷
关键词：
D O I：
10.1016/j.cca.2019.03.1205
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
W286
引用
收藏
页码：S574 / S574
页数：1
相关论文
共 50 条
  • [21] Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation
    Yamada, T.
    Yoshimura, A.
    Takeda, T.
    Shiotsu, S.
    Hiranuma, O.
    Chihara, Y.
    Uchino, J.
    Takayama, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1033 - S1033
  • [22] Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor
    Ku, Bo Mi
    Kim, Yeon Jeong
    Park, Donghyun
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    Sun, Jong-Mu
    ONCOLOGY, 2022, 100 (04) : 228 - 237
  • [23] Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer
    John, Thomas
    Bowden, Jeffrey J.
    Clarke, Stephen
    Fox, Stephen B.
    Garrett, Kerryn
    Horwood, Keith
    Karapetis, Christos S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (04) : 296 - 303
  • [24] Clinicopathological Characteristics of Non-small Cell Lung Cancer Patients With Primary Concomitant EGFR T790M Mutation
    Li, Hang
    Wang, Rui
    Hu, Haichuan
    Pan, Yunjian
    Wang, Lei
    Zhang, Yang
    Sun, Yihua
    Chen, Haiquan
    CHEST, 2014, 145 (03)
  • [25] Role of T790M Mutation in EGFR-TKI Rechallenge for Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer
    Zhang, Qiu-Yi
    Ke, E-E
    Deng, Wei
    Niu, Fei-Yu
    Zhao, Ning
    Su, Jian
    Chen, Zhi-Hong
    Yang, Jin-Ji
    Xu, Chong-Rui
    Yan, Hong-Hong
    Wu, Yi-Long
    Zhou, Qing
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S271 - S271
  • [26] EGFR Mutation Testing in Non-Small Cell Lung Cancer
    Sriram, Krishna B.
    Francis, Santiyagu M. Savarimuthu
    Tan, Maxine E.
    Bowman, Rayleen V.
    Yang, Ian A.
    Fong, Kwun M.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (04) : 310 - 321
  • [27] Circulating cell-free tumor DNA (cfDNA) testing in small cell lung cancer.
    Morgensztern, Daniel
    Devarakonda, Siddhartha H. K.
    Masood, Ashiq
    Waqar, Saiama Naheed
    Carmack, Alicia C.
    Banks, Kimberly C.
    Lanman, Richard Burnham
    Govindan, Ramaswamy
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Circulating tumor cells and T790M in metastatic non-small cell lung cancer patients with EGFR mutations and acquired resistance to TKI
    Isobe, Kazutoshi
    Hata, Yoshinobu
    Sato, Keita
    Sugino, Keishi
    Sano, Go
    Sakamoto, Susumu
    Takai, Yujiro
    Shibuya, Kazutoshi
    Takagi, Keigo
    Homma, Sakae
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Plasma cell-free DNA methylation combined with tumor mutation detection in prognostic prediction of patients with non-small cell lung cancer (NSCLC)
    Guo, Dan
    Yang, Liang
    Yang, Jianwei
    Shi, Ke
    MEDICINE, 2020, 99 (26) : E20431
  • [30] EGFR mutation analysis in circulating tumor cells and matched tumor of patients with non-small cell lung cancer
    Toh, Chee Keong
    Sng, Natasha
    Loh, Marie
    Wong, Alvin
    Yeo, Wee-Lee
    Chin, Tan Min
    Ng, Min-En
    Lim, Wan-Teck
    Soong, Richie
    Soo, Ross A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S928 - S928
12345